Back to Trials
NCT04548375RecruitingAccepts Healthy Volunteers

Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol

Cardio Surgical Partners

Start Date

11/1/2020

Completion Date

11/1/2026

Summary

The objective is to provide information to help the physician community decide the most effective type of device/therapy that would work for their patients, based off of the etiology of pain, the location of the pain for sustained pain relief.

Detailed Description

This registry will enroll patients that qualify for an SCS implant, for approved pain areas, as defined by medicare guidelines, and follow these patients for up to 12 months for denovo implants. For patients who have lost their pain relief over time, with a prior implanted device, this registry will follow a change out to another vendor/therapy, and follow those patients for up to 12 months.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * FDA approved indications for SCS implants, for commercial and government(medicare, medi-cal etc) approved payors Exclusion Criteria: \-

Interventions

DEVICE

SCS

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

SCS

Locations

Summit Surgery Center

Reno, Nevada 89511

United States